An official American thoracic society workshop report: Evaluation and management of asthma in the elderly

behalf of the ATS ad hoc Committee on Asthma in the Elderly

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Asthma in the elderly (.65 yr old) is common and associated with higher morbidity and mortality than asthma in younger patients. The poor outcomes in this group are due, in part, to underdiagnosis and undertreatment.There are a varietyof factors related toagingitself that affect the presentation of asthma in the elderly and influence diagnosis and management. Structural changes in the aging lung superimposed on structural changes due to asthma itself can worsen the disease and physiologic function. Changes in the aging immune system influence the cellular compositionandfunction inasthmatic airways.Theseprocesses and differences from younger individuals with asthma are not well understood. Phenotypes of asthmain the elderlyhavenot been clearlydelineated, but it is likely that age of onset and overlap with chronic obstructive pulmonary disease impact disease characteristics. Physiologic tests and biomarkers used to diagnoseandfollow asthmaintheelderly are generally similar to testing in younger individuals;however,whether they shouldbemodified in aginghas not been established. Confounding influences, such as comorbidities (increasing the risk of polypharmacy), impaired cognition and motor skills, psychosocial effects of aging, and age-related adverse effects ofmedications, impact both diagnosis and treatment of asthma in the elderly. Future efforts to understand asthma in the elderly must include geriatric-specific methodology to diagnose, characterize, monitor, and treat their disease.

Original languageEnglish (US)
Pages (from-to)2064-2077
Number of pages14
JournalAnnals of the American Thoracic Society
Volume13
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Thorax
Asthma
Education
Polypharmacy
Motor Skills
Age of Onset
Individuality
Geriatrics
Chronic Obstructive Pulmonary Disease
Cognition
Comorbidity
Immune System
Biomarkers
Morbidity
Phenotype
Lung
Mortality

Keywords

  • Aging
  • Immunosenescence
  • Lung function
  • Phenotype
  • Reactive airways disease

ASJC Scopus subject areas

  • Medicine(all)
  • Pulmonary and Respiratory Medicine

Cite this

An official American thoracic society workshop report : Evaluation and management of asthma in the elderly. / behalf of the ATS ad hoc Committee on Asthma in the Elderly.

In: Annals of the American Thoracic Society, Vol. 13, No. 11, 01.11.2016, p. 2064-2077.

Research output: Contribution to journalArticle

behalf of the ATS ad hoc Committee on Asthma in the Elderly. / An official American thoracic society workshop report : Evaluation and management of asthma in the elderly. In: Annals of the American Thoracic Society. 2016 ; Vol. 13, No. 11. pp. 2064-2077.
@article{b588085ae3cd4ea39fff605da06d1d97,
title = "An official American thoracic society workshop report: Evaluation and management of asthma in the elderly",
abstract = "Asthma in the elderly (.65 yr old) is common and associated with higher morbidity and mortality than asthma in younger patients. The poor outcomes in this group are due, in part, to underdiagnosis and undertreatment.There are a varietyof factors related toagingitself that affect the presentation of asthma in the elderly and influence diagnosis and management. Structural changes in the aging lung superimposed on structural changes due to asthma itself can worsen the disease and physiologic function. Changes in the aging immune system influence the cellular compositionandfunction inasthmatic airways.Theseprocesses and differences from younger individuals with asthma are not well understood. Phenotypes of asthmain the elderlyhavenot been clearlydelineated, but it is likely that age of onset and overlap with chronic obstructive pulmonary disease impact disease characteristics. Physiologic tests and biomarkers used to diagnoseandfollow asthmaintheelderly are generally similar to testing in younger individuals;however,whether they shouldbemodified in aginghas not been established. Confounding influences, such as comorbidities (increasing the risk of polypharmacy), impaired cognition and motor skills, psychosocial effects of aging, and age-related adverse effects ofmedications, impact both diagnosis and treatment of asthma in the elderly. Future efforts to understand asthma in the elderly must include geriatric-specific methodology to diagnose, characterize, monitor, and treat their disease.",
keywords = "Aging, Immunosenescence, Lung function, Phenotype, Reactive airways disease",
author = "{behalf of the ATS ad hoc Committee on Asthma in the Elderly} and Skloot, {Gwen S.} and Busse, {Paula J.} and Braman, {Sidney S.} and Kovacs, {Elizabeth J.} and Dixon, {Anne E.} and {Vaz Fragoso}, {Carlos A.} and Nicola Scichilone and Y.s. Prakash and Pabelick, {Christina M} and Mathur, {Sameer K.} and Hanania, {Nicola A.} and Moore, {Wendy C.} and Gibson, {Peter G.} and Susan Zieman and Ragless, {Betina B.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1513/AnnalsATS.201608-658ST",
language = "English (US)",
volume = "13",
pages = "2064--2077",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "11",

}

TY - JOUR

T1 - An official American thoracic society workshop report

T2 - Evaluation and management of asthma in the elderly

AU - behalf of the ATS ad hoc Committee on Asthma in the Elderly

AU - Skloot, Gwen S.

AU - Busse, Paula J.

AU - Braman, Sidney S.

AU - Kovacs, Elizabeth J.

AU - Dixon, Anne E.

AU - Vaz Fragoso, Carlos A.

AU - Scichilone, Nicola

AU - Prakash, Y.s.

AU - Pabelick, Christina M

AU - Mathur, Sameer K.

AU - Hanania, Nicola A.

AU - Moore, Wendy C.

AU - Gibson, Peter G.

AU - Zieman, Susan

AU - Ragless, Betina B.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Asthma in the elderly (.65 yr old) is common and associated with higher morbidity and mortality than asthma in younger patients. The poor outcomes in this group are due, in part, to underdiagnosis and undertreatment.There are a varietyof factors related toagingitself that affect the presentation of asthma in the elderly and influence diagnosis and management. Structural changes in the aging lung superimposed on structural changes due to asthma itself can worsen the disease and physiologic function. Changes in the aging immune system influence the cellular compositionandfunction inasthmatic airways.Theseprocesses and differences from younger individuals with asthma are not well understood. Phenotypes of asthmain the elderlyhavenot been clearlydelineated, but it is likely that age of onset and overlap with chronic obstructive pulmonary disease impact disease characteristics. Physiologic tests and biomarkers used to diagnoseandfollow asthmaintheelderly are generally similar to testing in younger individuals;however,whether they shouldbemodified in aginghas not been established. Confounding influences, such as comorbidities (increasing the risk of polypharmacy), impaired cognition and motor skills, psychosocial effects of aging, and age-related adverse effects ofmedications, impact both diagnosis and treatment of asthma in the elderly. Future efforts to understand asthma in the elderly must include geriatric-specific methodology to diagnose, characterize, monitor, and treat their disease.

AB - Asthma in the elderly (.65 yr old) is common and associated with higher morbidity and mortality than asthma in younger patients. The poor outcomes in this group are due, in part, to underdiagnosis and undertreatment.There are a varietyof factors related toagingitself that affect the presentation of asthma in the elderly and influence diagnosis and management. Structural changes in the aging lung superimposed on structural changes due to asthma itself can worsen the disease and physiologic function. Changes in the aging immune system influence the cellular compositionandfunction inasthmatic airways.Theseprocesses and differences from younger individuals with asthma are not well understood. Phenotypes of asthmain the elderlyhavenot been clearlydelineated, but it is likely that age of onset and overlap with chronic obstructive pulmonary disease impact disease characteristics. Physiologic tests and biomarkers used to diagnoseandfollow asthmaintheelderly are generally similar to testing in younger individuals;however,whether they shouldbemodified in aginghas not been established. Confounding influences, such as comorbidities (increasing the risk of polypharmacy), impaired cognition and motor skills, psychosocial effects of aging, and age-related adverse effects ofmedications, impact both diagnosis and treatment of asthma in the elderly. Future efforts to understand asthma in the elderly must include geriatric-specific methodology to diagnose, characterize, monitor, and treat their disease.

KW - Aging

KW - Immunosenescence

KW - Lung function

KW - Phenotype

KW - Reactive airways disease

UR - http://www.scopus.com/inward/record.url?scp=84995480052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995480052&partnerID=8YFLogxK

U2 - 10.1513/AnnalsATS.201608-658ST

DO - 10.1513/AnnalsATS.201608-658ST

M3 - Article

C2 - 27831798

AN - SCOPUS:84995480052

VL - 13

SP - 2064

EP - 2077

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 11

ER -